Eli Lilly and Novo Nordisk are expected to price their new obesity pills in line with existing injections, as analysts cite ...

AI is speeding up drug discovery by designing new medicines faster and cheaper. It scans data, creates new molecules, and ...

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

A group of vaccine-skeptical doctors and mandate opponents is challenging the CDC’s childhood immunization schedule in ...

For savvy investors looking for long-term businesses that not only dominate their industries today but also have the ...

Software giant Adobe (NASDAQ:ADBE) announced the launch of Acrobat Studio on Tuesday, a new platform the company said is designed to merge productivity, creativity and artificial intelligence into a ...

Intel (NASDAQ: INTC) stock rose 5.4% after the Japanese tech conglomerate Softbank (OTC: SFTBY) agreed to buy $2 billion ...

Investing.com -- Novo Nordisk and Eli Lilly (NYSE: LLY) shares edged higher Tuesday following results from Viking Therapeutics’ Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment. Novo ...

Trump’s possible next move, Winklevoss twins jump into hot IPO market, Palo Alto Networks issues rosy guidance, and more news ...

ORLANDO, FL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Endocrinology Drugs Market during the forecasted period 2025-2032 The ...

HR Asia Best Companies to Work for in Asia organized by Business Media International proudly honours 102 organizations that ...

Eli Lilly and Company (NYSE:LLY) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 14, Reuters reported that Eli Lilly and Company (NYSE:LLY) has entered into a deal worth $1 ...